Outcomes of Patients with Accelerated/Blast-Phase Myeloproliferative Neoplasms in the Current Era of Myeloid Therapies
Anand Patel(Ascension), Olatoyosi Odenike(University of Chicago), Ellen Madarang(University of Miami), Madelyn Burkart(Atrium Health Wake Forest Baptist), Yasmin Abaza(Northwestern University), John Cursio, Hannah Johnston(University of Illinois Chicago), Timothy S. Oh(Northwestern University), Evan C. Chen(Dana-Farber Cancer Institute), Iyana Gross(University of Chicago), Kristen Pettit(University of Michigan), Terrence Bradley(University of Miami Health System), Vikas Gupta(Indian Institute of Technology Kanpur), James Yoon(Beth Israel Deaconess Medical Center), Sunil Iyer(University of Miami), Jacqueline S. Garcia(Dana-Farber Cancer Institute), Rory M. Shallis(Smilow Cancer Hospital), Guru Subramanian Guru Murthy(Medical College of Wisconsin)
Cited by 6
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
|Cancer Cell|2016|304